← Leaderboards
Stacy Andersen
Boston Medical Center
$7,706,531
Attributed
$7,706,531
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $21.9M · FY2018–25$25M$18.8M$12.5M$6.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,817,361 · 6
By mechanism
U19$46,221,457 · 5
K01$595,904 · 1
Top collaborators
- Thomas T Perls9 shared
- Susan Y Bookheimer7 shared
- Kaare Christensen2 shared
- Stephanie Ann Cosentino2 shared
- Vonetta M Dotson2 shared
- Joseph Hyungwoo Lee2 shared
- Anne B Newman2 shared
- Michael A Province2 shared
Most similar at Boston Medical Center
Same institution · by research overlap
- Steve Williams$970,612
- Dellara F. Terry$992,157
- Barbara Susanne Nikolajczyk$8,738,431
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposCognitivePhenotypeResilienceNeuropsychologyImpaired CognitionCognitive FunctionNeuroimagingBrainDementiaS DiseaseOffspringBiologicalResistanceSamplingParticipantLongevitySpousesCentenarianNeuropathologyTissuesAreaPlasmaFunding
Grant awards (20)
The Long Life Family Study$15,098,513
U19 · FY2025 · AG
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$4,630,951
U19 · FY2025 · AG
Phenotyping and Biospecimen Core$1,278,473
U19 · FY2025 · AG · contact PI
The Long Life Family Study$913,176
U19 · FY2025 · AG
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$4,696,857
U19 · FY2024 · AG
Phenotyping and Biospecimen Core$1,357,637
U19 · FY2024 · AG · contact PI
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$4,345,136
U19 · FY2023 · AG
Phenotyping and Biospecimen Core$1,465,216
U19 · FY2023 · AG · contact PI
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$458,286
U19 · FY2023 · AG
Phenotyping and Biospecimen Core$77,970
U19 · FY2023 · AG · contact PI
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$4,355,918
U19 · FY2022 · AG
Phenotyping and Biospecimen Core$1,440,598
U19 · FY2022 · AG · contact PI
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$333,006
U19 · FY2022 · AG
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia$119,133
K01 · FY2022 · AG · contact PI
Resilience/Resistance to Alzheimer's Disease in Centenarians and Offspring (RADCO)$4,278,987
U19 · FY2021 · AG
Phenotyping and Biospecimen Core$1,490,733
U19 · FY2021 · AG · contact PI
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia$119,138
K01 · FY2021 · AG · contact PI
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia$119,153
K01 · FY2020 · AG · contact PI
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia$119,205
K01 · FY2019 · AG · contact PI
Digital Markers of Cognition Across the Spectrum of Preclinical Cognitive Impairment to Dementia$119,275
K01 · FY2018 · AG · contact PI